BSE filing, NSE: BGIL. Summary written from the filing by ALFA Finder's alert engine.
BGIL Films & Technologies Ltd: key numbers
- Share price
- ₹6.49
- Market cap
- ₹7.35 Cr
- Revenue (annual)
- ₹1.02 Cr
- Net profit (annual)
- ₹0.10 Cr
- P/E (TTM)
- 35.7×Sector 27.9×
- Promoter holding
- 41.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from BGIL Films & Technologies Ltd
All →BGIL Films & Technologies Board Meeting Date
BGIL Films & Technologies will hold a board meeting on 3 November 2026 to consider unaudited standalone half-year financial results for the period ended September 2026. The trading window closes from 26 October 2026 until 3 November 2026.
BGIL Films & Technologies Other Announcement
The company submitted its quarterly shareholding pattern as per SEBI Regulation 31(1)(b). This disclosure provides updated details of promoter and public shareholding for the quarter.
BGIL Films & Technologies Annual General Meeting
BGIL Films & Technologies Limited held its 37th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, borrowing limits, and related party transactions.
BGIL Films & Technologies Other Announcement
BGIL Films & Technologies Ltd has announced the book closure dates from September 24, 2026, to September 30, 2026, for its 37th Annual General Meeting.
BGIL Films & Technologies Annual General Meeting
BGIL Films & Technologies Ltd issued a notice for its 37th Annual General Meeting to be held on September 30, 2026, via video conferencing.
BGIL Films & Technologies Management Change
BGIL Films & Technologies Ltd announced the resignation of Mr. Premkumar Sitaram Mahato, cessation of Mr. Rohit Kaushik, and re-appointment of Mr. Karn Rajhans as Independent Directors.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.